ArticleRheumatology and immunology research2026
Health service capacity of rheumatology and immunology departments in China: A cross-sectional study of young and middle-aged physicians.
Article in Rheumatology and immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Rheumatic diseases are among the most prevalent chronic health conditions worldwide. This study aimed to systematically assess the diagnostic, therapeutic, and service capabilities of rheumatology and immunology departments across China. Methods: A questionnaire-based survey was conducted among young and middle-aged rheumatologists from May to November 2023. The questionnaire collected data on demographics, departmental infrastructure, and service capabilities. Results: A total of 2047 rheumatologists from 934 hospitals completed the survey. Among the participating hospitals, 817 (87.5%) were tertiary institutions. Most respondents (1970/2047, 96.5%) reported that their hospitals had rheumatology and immunology departments. With respect to the departmental scale, 65.0% of the respondents reported having 20-50 inpatient beds, and 39.0% (603/1546) of the departments had 6-10 physicians. Only 33.8% (691/2045) of the hospitals were capable of performing basic immunologic blood tests. The availability of key modalities was as follows: dual-energy CT (60.6%, 1238/2044), musculoskeletal ultrasound (87.0%, 1778/2044), sacroiliac joint CT (90.9%, 1857/2044), labial gland biopsy (81.3%, 1662/2044), renal biopsy (80.6%, 1647/2044), and synovial biopsy (62.6%, 1280/2044). Most surveyed physicians used Western medicine for patient treatment. In addition, 89.0% (1806/2030) of the respondents reported conducting follow-up for patients with chronic rheumatic disease. Conclusions: Rheumatology is among the fastest-growing specialties. Our survey highlights the need to enhance public awareness, optimize specialist training, and strengthen healthcare delivery and academic research. With increasing national attention, we anticipate considerable advancements in the fields of rheumatology and immunology in China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.